New fluoro derivatives of aralkylamine compounds, particularly 2-(2-phenyl-1,1,2,2-tetrafluoroethyl)benzylamine, as well as the N-alkyl and the N,N-dialkyl derivatives thereof are prepared by reaction of 2-bromobenzonitrile with benzylmagnesium chloride to produce 2'-bromo-2-phenylacetophenone; oxidation of said acetophenone with selenous acid to produce 2-bromobenzil; conversion of the benzil compound by treatment with sulfur tetrafluoride to the corresponding 2-bromo-.alpha. ,.alpha.-.alpha.',.alpha.'-tetrafluorobibenzyl; followed by reaction of the 2-bromobibenzyl compound with a metal cyanide to produce the corresponding 2-(2-phenyl-1,1,2,2-tetrafluoroethyl)benzonitrile. This nitrile compound is then reduced with lithium aluminum hydride to produce the corresponding benzylamine, which is then converted, if desired, to the N-alkyl and/or N,N-dialkyl 2-(2-phenyl-1,1,2,2-tetrafluoroethyl)benzylamine. Alternatively, the nitrile or the precursor bromobibenzyl can be converted by Grignard reactions to the corresponding .alpha.-alkyl or .alpha.,.alpha.-dialkylbenzylamine which can then be converted if desired to the corresponding N-alkyl and/or N,N-dialkyl substituted benzylamine compound. The phenyltetrafluoroethylbenzylamine as well as its N-alkyl and N,N-dialkyl derivatives are active as antiarrhythmic agents.
新的芳基烷基胺衍
生物,特别是2-(2-苯基-1,1,2,2-四
氟乙基)苯
甲胺及其N-烷基和N,N-二烷基衍
生物,通过2-
溴苯甲腈与
苄基氯化镁反应制备2'-
溴-2-
苯乙酮;使用亚
硒酸氧化该
苯乙酮以产生2-
溴苯并酮;将苯并酮化合物通过
硫四
氟化物处理转化为相应的2-
溴-.alpha.,.alpha.-.alpha.',.alpha.'-四
氟双苯基;随后将2-
溴双苯基化合物与
金属
氰化物反应,以产生相应的2-(2-苯基-1,1,2,2-四
氟乙基)
苯甲腈。然后使用
锂铝
氢化物还原这种腈化合物以产生相应的
苄胺,如果需要,将其转化为N-烷基和/或N,N-二烷基的2-(2-苯基-1,1,2,2-四
氟乙基)苯
甲胺。或者,腈或前体
溴双苯基可以通过
格氏试剂反应转化为相应的α-烷基或α,α-二烷基苯
甲胺,如果需要,可以将其转化为相应的N-烷基和/或N,N-二烷基取代的
苄胺化合物。苯基四
氟乙基苯甲胺及其N-烷基和N,N-二烷基衍
生物作为
抗心律失常药物具有活性。